Integrins in the Spotlight of Cancer

by Daniela Bianconi, Matthias Unseld, Gerald W. Prager
Published 2016-12-01

A real-world analysis of second-line treatment options in pancreatic cancer: liposomal-irinotecan plus 5-fluorouracil and folinic acid

by Markus Kieler, Matthias Unseld, Daniela Bianconi, Werner Scheithauer, Gerald W. Prager
Published 2019-07-01

Applied precision medicine in metastatic pancreatic ductal adenocarcinoma

by Hossein Taghizadeh, Leonhard Müllauer, Robert M. Mader, Martin Schindl, Gerald W. Prager
Published 2020-07-01

Outcome of Targeted Therapy Recommendations for Metastatic and Recurrent Head and Neck Cancers

by Hossein Taghizadeh, Robert M. Mader, Leonhard Müllauer, Thorsten Fuereder, Alexandra Kautzky-Willer, Gerald W. Prager
Published 2020-11-01

Precision Medicine for the Management of Therapy Refractory Colorectal Cancer

by Hossein Taghizadeh, Robert M. Mader, Leonhard Müllauer, Friedrich Erhart, Alexandra Kautzky-Willer, Gerald W. Prager
Published 2020-12-01

Impact of New Chemotherapy Regimens on the Treatment Landscape and Survival of Locally Advanced and Metastatic Pancreatic Cancer Patients

by Markus Kieler, Matthias Unseld, Daniela Bianconi, Martin Schindl, Gabriela V. Kornek, Werner Scheithauer, Gerald W. Prager
Published 2020-02-01

Gender differences in molecular‐guided therapy recommendations for metastatic malignant mesothelioma

by Hossein Taghizadeh, Sabine Zöchbauer‐Müller, Robert M. Mader, Leonhard Müllauer, Thomas Klikovits, Thomas Bachleitner‐Hofmann, Mir A. Hoda, Gerald W. Prager
Published 2020-07-01

Different Toxicity Profiles Predict Third Line Treatment Efficacy in Metastatic Colorectal Cancer Patients

by Matthias Unseld, Sebastian Fischöder, Mathias Jachs, Magdalena Drimmel, Alexander Siebenhüner, Daniela Bianconi, Markus Kieler, Hannah Puhr, Christoph Minichsdorfer, Thomas Winder, Gerald W. Prager
Published 2020-06-01

Biochemical and genetic predictors of overall survival in patients with metastatic pancreatic cancer treated with capecitabine and nab-paclitaxel

by Daniela Bianconi, Gerwin Heller, Daniel Spies, Merima Herac, Andreas Gleiss, Sandra Liebmann-Reindl, Matthias Unseld, Markus Kieler, Werner Scheithauer, Berthold Streubel, Christoph C. Zielinski, Gerald W. Prager
Published 2017-07-01

SERPINB7 Expression Predicts Poor Pancreatic Cancer Survival Upon Gemcitabine Treatment

by Daniela Bianconi, Merima Herac, Daniel Spies, Markus Kieler, Robert Brettner, Matthias Unseld, Katrin Fürnkranz, Barbara Famler, Margit Schmeidl, Christoph Minichsdorfer, Christoph Zielinski, Gerwin Heller, Gerald W. Prager
Published 2019-01-01

Interim analysis of a real-world precision medicine platform for molecular profiling of metastatic or advanced cancers: MONDTI

by Christoph C Zielinski, Markus Kieler, Matthias Unseld, Daniela Bianconi, Fredrik Waneck, Robert Mader, Fritz Wrba, Thorsten Fuereder, Philipp Staber, Walter Berger, Maria Sibilia, Stephan Polterauer, Leonhard Müllauer, Gerald W Prager
Published 2019-07-01

Targeted Therapy Recommendations for Therapy Refractory Solid Tumors—Data from the Real-World Precision Medicine Platform MONDTI

by Hossein Taghizadeh, Matthias Unseld, Martina Spalt, Robert M. Mader, Leonhard Müllauer, Thorsten Fuereder, Markus Raderer, Maria Sibilia, Mir Alireza Hoda, Stefanie Aust, Stephan Polterauer, Wolfgang Lamm, Rupert Bartsch, Matthias Preusser, Kautzky-Willer A., Gerald W. Prager
Published 2020-10-01